CXCR3

CXC chemokine receptor 3 (CXCR3) is a G protein-coupled receptor that mediates leukocyte chemotaxis and modulates immune responses^[1][2]. Mechanistically, CXCR3 signaling is triggered by ligands including CXCL9, CXCL10, CXCL11, CXCL4, and CXCL4L1, which activate downstream pathways such as PI3K/Akt, ERK, and p38 MAPK, leading to directed cell migration and adhesion^[3][4][5]. In endothelial cells, CXCR3 limits angiogenesis and promotes pericyte recruitment, thereby stabilizing vascular networks during development and tissue repair^[6][7][8]. CXCR3 isoforms exhibit distinct functions: CXCR3A enhances tumor cell migration and pro-inflammatory responses, whereas CXCR3B mediates anti-tumor effects and regulates pericyte function^[9][10][8]. Disease models highlight CXCR3’s relevance in cancer metastasis, inflammatory disorders, intracerebral hemorrhage, and infectious diseases, with ligand-specific activation controlling endothelial integrity, immune cell recruitment, and tissue inflammation^{[5][2][9][11]}. Small-molecule inhibitors and agonists, including AMG487 and SCH546738, demonstrate isoform-selective effects, with CXCR3A more sensitive to inhibition than CXCR3B, supporting targeted therapeutic strategies^[1][9][3]. Differential subcellular localization further regulates biased signaling via G proteins and β-arrestins, emphasizing the importance of spatial dynamics for experimental and clinical applications^[4]. Collectively, CXCR3 represents a versatile receptor linking chemotactic signaling, vascular stability, and disease modulation.